Atlas Trials

Phase 2 Study of the ТВ/Flu-05Е Tuberculosis Vaccine

Clinical trial NCT06873282 · COMPLETED

Trial details

NCT number
NCT06873282
Sponsor
Research Institute of Influenza, Russia
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Tuberculosis
Start date
2023-12-13
Primary completion
2024-01-12
Enrollment
160

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.